KREF · KKR Real Estate Finance Trust Inc.
$7.51
+0.23 (+3.16%)
At close · Aug 19
Market Cap
$439.92M
Shares
58.58M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$7.51
Open$7.39
Day$7.39–7.63
52W close$5.88–9.87
Avg vol 30d1.1M
Short int5.2M · 8.9% float · 3.5d
Short vol73%
Last earningsJul 22, 2026
DataJan 2020–Aug 2026
Filing10-Q · Jul 21
Up next
Next earnings call
Oct 21, 2026
Est · unconfirmed
· in 9 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Jul 21, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Buy
Momentum
Weak
Sentiment
Neutral
Fundamentals
Weak
Quant / Vol
High
Market backdrop
VIX 14.9 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+3%
above
Price vs 50-day avg
+3%
above
RSI (14)
53
neutral
MACD trend
Negative
52-week position
41%
mid-range
Momentum
relative strength
1-month return
+1%
trailing
6-month return
+7%
trailing
YTD return
−9%
this year
Relative strength
−5%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $7 › 200d $7 — 200d above 50d
Institutional flow
Distributing
-9% holders QoQ · +34 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
8.95% of float · ▼ -6.7% MoM · 3.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
153 holders — near 3-yr low, contrarian setup
Squeeze score
71
high risk · 0–100
Fundamentals
Revenue growth
−2%
Y/Y
EPS growth
−653%
Y/Y
Buyback
$37.0M
remaining
Balance sheet
$6.1B
net debt
Quant / Vol
risk profile
Volatility
32%
annualized · 1-yr
Max drawdown
−40%
past year
ATR
3.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the Earnings Call filed Mar 31, 2026
through the year (2026)
Capital to invest
$500M
2026
Expected repayments
$2B
quarterly
Dividend per share
$0.10
per year
Annual dividends per share
$0.40
second quarter (of 2026)
Realized loss (Boston Life Science expected transition to REO)
$37M
Prior guidance
period ended
· from the Earnings Call filed Sep 30, 2025
Originations
· fourth quarter
$400M
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+3%
Bullish
Price vs 50-day avg
+3%
Bullish
RSI (14)
53
Neutral
MACD trend
Negative
Bearish
52-week position
41%
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $7 › 200d $7 — 200d above 50d
Institutional flow
Distributing
-9% holders QoQ · +34 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
8.95% of float · ▼ -6.7% MoM · 3.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
153 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $6
Now $8 · 41%
Range high $10
vs 200-day avg +3%
vs 50-day avg +3%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Average Loan Size | $101M | 2Q'26 | — |
| Average risk rating of the loan portfolio | 3.3 | Q2 2026 | — |
|
|
|||
| Common book value per share | $10.24 | Q2 2026 | — |
| Common Shares Outstanding | 58,577,948 | 2Q'26 | — |
| Current Liquidity | $722M | 2Q'26 | — |
| Current loan portfolio | 4.5B | Q2 2026 | — |
| Distributable Earnings (Loss) non-GAAP | -$36.4M | 2Q'26 | — |
GAAP → non-GAAP reconciliationGAAP Net Income (Loss) Attributable to Common Stockholders -121.79M
+1.9M Non-cash equity compensation expense
+1.56M Depreciation and amortization
+1.68M Unrealized (gain) loss on investments
-2.55M Unrealized (gain) loss on foreign currency translation
+5.33M Unrealized (gain) loss on foreign currency forward contracts
+119.84M Provision for loan losses, net
+0K (Gain) loss on sale of real estate owned
-42.34M Realized loss on loan write-offs
+0K Realized gain (loss) on sale of real estate owned
= Distributable Earnings (Loss) -36.37M
|
|||
| Distributable Earnings (Loss) per diluted share non-GAAP | -$0.58 | Q2 2026 | — |
GAAP → non-GAAP reconciliationGAAP Net Income (Loss) Per Share of Common Stock, Basic and Diluted -$1.95
+$0.03 Non-cash equity compensation expense
+$0.03 Depreciation and amortization
+$0.03 Unrealized (gain) loss on investments
-$0.04 Unrealized (gain) loss on foreign currency translation
+$0.09 Unrealized (gain) loss on foreign currency forward contracts
+$1.92 Provision for loan losses, net
+$0 (Gain) loss on sale of real estate owned
-$0.68 Realized loss on loan write-offs
+$0 Realized gain (loss) on sale of real estate owned
= Distributable Earnings (Loss) Per Diluted Share -$0.58
|
|||
| Diversified financing sources | 7B | Q2 2026 | — |
|
|
|||
| Financing Capacity | 7B | 2Q'26 | — |
| Fully extended weighted average loan maturity | 1.9 | Q2 2026 | — |
| Funded loans | $328M | 2Q'26 | — |
| Global AUM | 758B | as of March 31, 2026 | — |
| KKR Ownership in KREF | 17% | 2Q'26 | — |
| Liquidity position | 721.6M | Q2 2026 | — |
|
|
|||
| Loan originations committed | 348.6M | Q2 2026 | — |
|
|
|||
| Loan originations funded | 328.3M | Q2 2026 | — |
|
|
|||
| Loan Portfolio | 4.5B | 2Q'26 | — |
|
|
|||
| Loan repayments received | 806.6M | Q2 2026 | — |
|
|
|||
| Originated loans | $349M | 2Q'26 | — |
| Real Estate AUM | 84B | as of March 31, 2026 | — |
| Undrawn financing capacity | 2.6B | Q2 2026 | — |
|
|
|||
| Weighted Average Coupon | 3% | Q2 2026 | — |
| Weighted Average LTV | 66% | Q2 2026 | — |
| Weighted average unlevered all-in yield | 6.8% | Q2 2026 | — |
| Weighted average LTV at origination | 66% | Q1 2026 | — |
| Distributable Earnings non-GAAP | $26.3M | year ended December 31, 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
REIT - Mortgage — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
KREF
this stock
KKR Real Estate Finance Trust Inc.
|
$439.92M | -8.6% | -1.8% | — | 8.9% |
|
NLY
Annaly Capital Management Inc
|
$17.89B | +6.2% | — | — | 2.8% |
|
AGNC
AGNC Investment Corp.
|
$12.95B | +3.4% | — | — | 8.4% |
|
STWD
Starwood Property Trust, Inc.
|
$6.02B | -8.1% | -5.3% | — | 4.9% |
|
RITM
Rithm Capital Corp.
|
$5.72B | -4.8% | -6.7% | 17.1 | 7.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| KREF | -2.0% | +1.4% | +7.0% | +7.9% | -8.6% |
| SPY | -0.4% | +2.9% | +11.6% | +3.0% | +12.8% |
| vs SPY | -1.5% | -1.6% | -4.6% | +5.0% | -21.4% |
Capital returns
Latest dividend
$0.10
/ share · ex Jun 30, 2026
Paid (TTM)
$0.85
/ share · 4 payouts
Dividend yield (TTM, derived)
11.32%
Buyback program
· as of Jun 30, 2026
Authorized
$75.00M
Spent (derived)
$38.00M
Remaining
$37.00M
Spent
Remaining
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.